Emma Blaney

Current Organisation: C4X DISCOVERY LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£139,640

Jan 17 - Dec 17

Oral Agonists of GPR142, an Innovative New Target for the Treatment of Type 2 Diabetes

Innovate UK award to C4X DISCOVERY LIMITED and Emma Blaney

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}